ArticleOncology letters2023

Apatinib combined with trastuzumab and albumin-bound paclitaxel for treatment of HER2+ breast cancer with brain metastases resistant to anti-HER2 TKIs: A case report.

Jiayi Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.